These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 27423657

  • 1. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L, Heikkinen T, Sackeyfio A, Pitman R.
    Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
    Mennini FS, Bini C, Marcellusi A, Rinaldi A, Franco E.
    Hum Vaccin Immunother; 2018 Sep; 14(8):1867-1873. PubMed ID: 29708843
    [Abstract] [Full Text] [Related]

  • 4. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
    Crépey P, Boiron L, Araujo RR, Lopez JG, Petitjean A, de Albuquerque Luna EJ.
    BMC Public Health; 2020 Sep 09; 20(1):1374. PubMed ID: 32907562
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
    Yang MC, Tan EC, Su JJ.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):81-89. PubMed ID: 27624648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ.
    Value Health; 2021 Jan 02; 24(1):19-31. PubMed ID: 33431149
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
    Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M.
    BMC Public Health; 2016 Jul 22; 16():630. PubMed ID: 27449665
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):533-542. PubMed ID: 27780425
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA.
    Hum Vaccin Immunother; 2014 Mar 04; 10(5):1171-80. PubMed ID: 24609063
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.
    Dolk C, Eichner M, Welte R, Anastassopoulou A, Van Bellinghen LA, Poulsen Nautrup B, Van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma M.
    Pharmacoeconomics; 2016 Dec 04; 34(12):1299-1308. PubMed ID: 27647004
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Bellier L, Petitjean A, Sarazu T, Tresierra J, Lopez JG.
    Vaccine; 2021 Jul 05; 39(30):4144-4152. PubMed ID: 34130885
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M.
    BMC Med; 2017 Sep 08; 15(1):166. PubMed ID: 28882149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.